Stock listing
Aeon Biopharma, Inc.
Selected listing: AEON · AMEX · USD · US
Aeon Biopharma, Inc. (NYSE American: AEON), Health Technology. Latest release Aug 12, 2026: AEON Biopharma Reports Second Quarter 2026 Financial Results…
- Ticker
- NYSE American: AEON
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NYSE American
- Currency
- USD
About Aeon Biopharma, Inc.
Aeon Biopharma, Inc. is a public company traded under the ticker AEON in the American market. Aeon Biopharma focuses on developing innovative therapies in the biopharmaceutical sector.
Latest news from Aeon Biopharma, Inc.
AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 12, 2026
AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards
August 3, 2026
AEON Biopharma : Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding
July 14, 2026
AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding
July 14, 2026
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society
June 4, 2026
Research Aeon Biopharma, Inc.
Aeon Biopharma, Inc. company profile
View the public company page for Aeon Biopharma, Inc. on 6ix.
Aeon Biopharma, Inc. news
Read company news and market updates connected to Aeon Biopharma, Inc..
Aeon Biopharma, Inc. investor events
Find investor webinars, events, and replay context for Aeon Biopharma, Inc..